Endothelin Receptor Type A (EDNRA) Antibody

Este producto es parte de EDNR - Endothelin Receptor
Product Graph
221€ (50 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Endothelin Receptor Type A (EDNRA) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx328098
tested applications
ELISA, WB, IF/ICC

Description

EDNRA Antibody is a Rabbit Polyclonal against EDNRA.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Primary Antibodies
Immunogen Target
Endothelin Receptor Type A (EDNRA)
Host
Rabbit
Reactivity
Human, Mouse, Rat
Recommended Dilution
ELISA: 1/20000, WB: 1/500 - 1/2000, IF/ICC: 1/200 - 1/1000. Optimal dilutions/concentrations should be determined by the end user.
Clonality
Polyclonal
Conjugation
Unconjugated
Isotype
IgG
Purification
Purified by affinity chromatography.
Size 1
50 µg
Size 2
100 µg
Form
Liquid
Tested Applications
ELISA, WB, IF/ICC
Buffer
PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
Availability
Shipped within 5-10 working days.
Storage
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Dry Ice
No
UniProt ID
P25101
Gene ID
1909
Alias
EDNRA,ET-AR,ENDOR,endothelin A receptor,endothelin-1 receptor,Gpcr10,ETA,ET-A,ETAR,ETRA,MFDA,ETA-R,hET-AR,Endothelin 1 Receptor
Background
Antibody anti-EDNRA
Status
RUO

Descripción

EDNRA is a G protein-coupled receptor (GPCR) that binds endothelin-1 (ET-1) with high affinity, playing a critical role in regulating vascular tone, cell proliferation, and cardiac function. It is predominantly expressed on vascular smooth muscle cells, where its activation by ET-1 triggers potent vasoconstriction through downstream signaling pathways, including phospholipase C (PLC), protein kinase C (PKC), and calcium mobilization. EDNRA-mediated signaling is essential for maintaining blood pressure and vascular homeostasis but contributes to pathological conditions such as hypertension, pulmonary arterial hypertension (PAH), and atherosclerosis when dysregulated. In cancer, EDNRA is overexpressed in tumors, including breast, ovarian, and prostate cancers, where it promotes cell proliferation, survival, angiogenesis, and metastasis by enhancing ET-1 signaling. EDNRA activation also contributes to cardiac hypertrophy and fibrosis in heart failure, making it a therapeutic target for cardiovascular diseases. Pharmacological antagonists of EDNRA, such as endothelin receptor antagonists (ERAs), have shown efficacy in managing PAH and reducing vascular remodeling. Overall, EDNRA plays a vital role in vascular physiology and disease, with its dysregulation driving cardiovascular pathology and tumor progression.

Related Products

abx032836

Endothelin Receptor Type A (EDNRA) Antibody

EDNRA is a receptor for endothelin-1. Mediates its action by association with G proteins that activate a phosphatidylinositol-calcium second messenger system.

Ver Producto
abx119460

Endothelin Receptor Type A (EDNRA) Antibody

EDNRA Antibody is a Rabbit Polyclonal antibody against EDNRA.

Ver Producto
abx151411

Human Endothelin 1 Receptor (EDNRA) ELISA Kit

Human Endothelin 1 Receptor (EDNRA) ELISA Kit is an ELISA Kit for the in vitro quantitative measurement of Human Endothelin 1 Receptor (EDNRA) concentrations in serum, plasma, tissue homogenates and other biological fluids. This assay has high sensitivity and excellent specificity for detection of Endothelin Receptor A (ETRA)

Ver Producto